{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:59:03Z","timestamp":1790870343435,"version":"4.1.0"},"reference-count":242,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neubiorev.2011.06.007","type":"journal-article","created":{"date-parts":[[2011,6,26]],"date-time":"2011-06-26T21:06:40Z","timestamp":1309122400000},"page":"271-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":200,"title":["Smoking, quitting, and psychiatric disease: A review"],"prefix":"10.1016","volume":"36","author":[{"given":"Henri-Jean","family":"Aubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Rollema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torgny H.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Winterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2011.06.007_bib0005","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.2741\/2424","article-title":"Evidence for a role of nicotinic acetylcholine receptors in schizophrenia","volume":"12","author":"Adams","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/070674379704200107","article-title":"Readiness to stop smoking in schizophrenia","volume":"42","author":"Addington","year":"1997","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0015","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1176\/ajp.150.12.1856","article-title":"Normalization of auditory physiology by cigarette smoking in schizophrenic patients","volume":"150","author":"Adler","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0020","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0006-3223(92)90073-9","article-title":"Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics","volume":"32","author":"Adler","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0025","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0006-3223(85)90113-1","article-title":"Neurophysiologic studies of sensory gating in schizophrenia: comparison of auditory and visual responses","volume":"20","author":"Adler","year":"1985","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-2007-980115","article-title":"Tobacco prevention","volume":"61","author":"Andreas","year":"2007","journal-title":"Pneumologie"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0035","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1176\/appi.ajp.2010.10101501","article-title":"Current smoking, hypoxia, and suicide","volume":"168","author":"Aubin","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/10550490601080100","article-title":"Adolescents with conduct disorder: early smoking and treatment requests","volume":"16","author":"Bagot","year":"2007","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0091-3057(00)00205-7","article-title":"The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?","volume":"66","author":"Balfour","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-4328(00)00202-3","article-title":"The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence","volume":"113","author":"Balfour","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0055","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1360-0443.2010.02946.x","article-title":"Smoking cessation in severe mental illness: what works?","volume":"105","author":"Banham","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.schres.2007.11.027","article-title":"Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment","volume":"100","author":"Barr","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.npp.1301423","article-title":"The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls","volume":"33","author":"Barr","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/appi.psychotherapy.1991.45.1.78","article-title":"Psychotherapy with schizophrenics in team groups: a systems model","volume":"45","author":"Beeber","year":"1991","journal-title":"Am. J. Psychother."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0075","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/S0028-3908(00)00153-2","article-title":"[(3)H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day","volume":"39","author":"Benhammou","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","article-title":"Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics","volume":"49","author":"Benowitz","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/clpt.1988.107","article-title":"Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum","volume":"44","author":"Benowitz","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00426913","article-title":"Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles","volume":"63","author":"Benwell","year":"1979","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0095","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1471-4159.1988.tb10600.x","article-title":"Evidence that tobacco smoking increases the density of (\u2212)-[3H]nicotine binding sites in human brain","volume":"50","author":"Benwell","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0100","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/j.1360-0443.2010.03109.x","article-title":"Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day","volume":"105","author":"Berlin","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0105","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neubiorev.2010.02.006","article-title":"Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system","volume":"35","author":"Berrendero","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0110","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1360-0443.2003.00524.x","article-title":"A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation","volume":"98","author":"Biberman","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3122\/jabfm.2007.03.060115","article-title":"Barriers to the provision of smoking cessation services reported by clinicians in underserved communities","volume":"20","author":"Blumenthal","year":"2007","journal-title":"J. Am. Board Fam. Med."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0033291707001547","article-title":"Cigarette smoking and suicidal behaviour: results from a 25-year longitudinal study","volume":"38","author":"Boden","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0125","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.2105\/AJPH.2010.192252","article-title":"Population-attributable fractions of Axis I and Axis II mental disorders for suicide attempts: findings from a representative sample of the adult, noninstitutionalized US population","volume":"100","author":"Bolton","year":"2010","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0893-133X(00)00121-4","article-title":"Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia","volume":"23","author":"Breese","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(24)36798-9","article-title":"Effect of smoking history on [3H]nicotine binding in human postmortem brain","volume":"282","author":"Breese","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1991.01810360033005","article-title":"Nicotine dependence, major depression, and anxiety in young adults","volume":"48","author":"Breslau","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0145","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archpsyc.62.3.328","article-title":"Smoking and the risk of suicidal behavior: a prospective study of a community sample","volume":"62","author":"Breslau","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0150","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1469-7610.2006.01615.x","article-title":"Adolescent suicide and suicidal behavior","volume":"47","author":"Bridge","year":"2006","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2007.10.010","article-title":"Smoking predicts suicidality: findings from a prospective community study","volume":"108","author":"Bronisch","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0160","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/00004583-199612000-00011","article-title":"Cigarette smoking, major depression, and other psychiatric disorders among adolescents","volume":"35","author":"Brown","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2165\/00002018-200932020-00005","article-title":"A preliminary benefit-risk assessment of varenicline in smoking cessation","volume":"32","author":"Cahill","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0170","first-page":"CD006103","article-title":"Nicotine receptor partial agonists for smoking cessation","author":"Cahill","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0175","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1124\/jpet.302.3.1265","article-title":"Brain reward system activity in major depression and comorbid nicotine dependence","volume":"302","author":"Cardenas","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0180","first-page":"625","article-title":"Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 1997\u20132001","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0185","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/1471-2458-9-356","article-title":"A systematic review of longitudinal studies on the association between depression and smoking in adolescents","volume":"9","author":"Chaiton","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0920-9964(00)00026-8","article-title":"Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia","volume":"46","author":"Combs","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0195","doi-asserted-by":"crossref","first-page":"e2547","DOI":"10.1371\/journal.pone.0002547","article-title":"A vaccine against nicotine for smoking cessation: a randomized controlled trial","volume":"3","author":"Cornuz","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0200","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.pharmtox.40.1.431","article-title":"Nicotinic receptors at the amino acid level","volume":"40","author":"Corringer","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0205","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archgenpsychiatry.2009.41","article-title":"beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking","volume":"66","author":"Cosgrove","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuron.2007.03.006","article-title":"Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex","volume":"54","author":"Couey","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0306-4522(98)00088-8","article-title":"Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use","volume":"87","author":"Court","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0920-9964(93)90048-N","article-title":"Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia","volume":"10","author":"Cullum","year":"1993","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0225","unstructured":"Cytos Biotechnology AG. NIC002 (formerly CYT002-NicQb): a novel vaccine for nicotine addiction. Cytos Biotechnology AG. August 2007. Available at: http:\/\/www.cytos.com\/doc\/NIC002_Nicaddiction_Facts_August07.pdf (accessed October 1, 2010)."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0230","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1176\/ajp.155.11.1490","article-title":"Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings","volume":"155","author":"Dalack","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0235","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00004714-198810000-00007","article-title":"Paradoxical worsening of depressive symptomatology caused by antidepressants","volume":"8","author":"Damluji","year":"1988","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0240","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1176\/ajp.152.3.453","article-title":"Schizophrenia and smoking: an epidemiological survey in a state hospital","volume":"152","author":"de Leon","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","article-title":"A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors","volume":"76","author":"de Leon","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-9964(01)00217-1","article-title":"Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders","volume":"56","author":"de Leon","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00210-004-0960-3","article-title":"Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat","volume":"370","author":"de Villiers","year":"2004","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0260","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.encep.2007.04.003","article-title":"Smoking and schizophrenia: epidemiological and clinical features","volume":"34","author":"Dervaux","year":"2008","journal-title":"Encephale"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0265","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00023210-200115060-00005","article-title":"Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective","volume":"15","author":"Desai","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(00)00122-9","article-title":"Role of dopamine in the behavioural actions of nicotine related to addiction","volume":"393","author":"Di Chiara","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0275","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.comppsych.2009.12.001","article-title":"A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder","volume":"51","author":"Dodd","year":"2010","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0280","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/bmj.2.4682.739","article-title":"Smoking and carcinoma of the lung; preliminary report","volume":"2","author":"Doll","year":"1950","journal-title":"Br. Med. J."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0285","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0306-4603(85)90017-6","article-title":"Evidence of more rapid stimulus evaluation following cigarette smoking","volume":"10","author":"Edwards","year":"1985","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0290","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.4088\/JCP.v69n0620a","article-title":"Varenicline treatment for smokers with schizophrenia: a case series","volume":"69","author":"Evins","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0295","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1038\/sj.npp.1301617","article-title":"\u03b16-Containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens","volume":"33","author":"Exley","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0300","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1185\/03007990802707568","article-title":"Management of smoking cessation in patients with psychiatric disorders","volume":"25","author":"Fagerstr\u00f6m","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0310","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1046\/j.1460-9568.2001.02009.x","article-title":"Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections","volume":"15","author":"Ferrari","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0315","unstructured":"Fiore, M.C., Ja\u00e9n, C.R., Baker, T.B., Bailey, W.C., Benowitz, N.L., Curry, S.J., Dorfman, S.F., Froelicher, E.S., Goldstein, M.G., Healton, C.G., Henderson, P.N., Heyman, R.B., Koh, H.K., Kottke, T.E., Lando, H.A., Mecklenburg, R.E., Mermelstein, R.J., Mullen, P.D., Orleans, C.T., Robinson, L., Stitzer, M.L., Tommasello, A.C., Villejo, L., Wewers, M.E. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Executive Summary. U.S. Department of Health and Human Services. Public Health Service. May 2008. Available at: http:\/\/www.ahrq.gov\/path\/tobacco.htm#clinic (accessed October 1, 2010)."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0320","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1744-6163.2002.tb00656.x","article-title":"Schizophrenia and the motivation for smoking","volume":"38","author":"Forchuk","year":"2002","journal-title":"Perspect. Psychiatr. Care"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0325","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1176\/appi.ajp.2007.07020326","article-title":"Exacerbation of schizophrenia by varenicline","volume":"164","author":"Freedman","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0330","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/10673229409017136","article-title":"Schizophrenia and nicotinic receptors","volume":"2","author":"Freedman","year":"1994","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0335","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1176\/appi.ajp.2008.07071135","article-title":"Initial phase 2 trial of a nicotinic agonist in schizophrenia","volume":"165","author":"Freedman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0340","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12031-007-9016-8","article-title":"VTA dopamine neuron bursting is altered in an animal model of depression and corrected by desipramine","volume":"34","author":"Friedman","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0345","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1753944709335754","article-title":"Smoking cessation pharmacotherapy","volume":"3","author":"Frishman","year":"2009","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0350","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/JCP.0b013e318172b49e","article-title":"Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study","volume":"28","author":"George","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0355","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0006-3223(02)01454-3","article-title":"A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation","volume":"53","author":"George","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0360","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/070674370905400602","article-title":"Addressing tobacco dependence in psychiatric practice: promises and pitfalls","volume":"54","author":"George","year":"2009","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0365","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","article-title":"Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia","volume":"157","author":"George","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0370","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.1990.03450120058029","article-title":"Smoking, smoking cessation, and major depression","volume":"264","author":"Glassman","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0375","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1037\/a0014732","article-title":"Psychiatric diagnoses as contemporaneous risk factors for suicide attempts among adolescents and young adults: developmental changes","volume":"77","author":"Goldston","year":"2009","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0380","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0385","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","article-title":"Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0390","doi-asserted-by":"crossref","first-page":"b3805","DOI":"10.1136\/bmj.b3805","article-title":"Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database","volume":"339","author":"Gunnell","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0395","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.schres.2004.12.007","article-title":"Smoking initiation and schizophrenia: a replication study in a Spanish sample","volume":"76","author":"Gurpegui","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0400","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1037\/0022-006X.72.4.563","article-title":"Influences of mood, depression history, and treatment modality on outcomes in smoking cessation","volume":"72","author":"Haas","year":"2004","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0405","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1523\/JNEUROSCI.5129-06.2007","article-title":"Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network","volume":"27","author":"Hahn","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0410","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0028-3908(03)00099-6","article-title":"Attentional effects of nicotinic agonists in rats","volume":"44","author":"Hahn","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0415","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00213-002-1005-6","article-title":"Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands","volume":"162","author":"Hahn","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0420","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.clinpsy.032408.153614","article-title":"Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings","volume":"5","author":"Hall","year":"2009","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0425","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2105\/AJPH.2005.080382","article-title":"Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial","volume":"96","author":"Hall","year":"2006","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0430","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archpsyc.63.3.332","article-title":"Suicidality in pediatric patients treated with antidepressant drugs","volume":"63","author":"Hammad","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0435","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2004-832596","article-title":"A two-year study on the effects of nicotine and its withdrawal on mood and sleep","volume":"37","author":"Haro","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0440","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.170.3.205","article-title":"Suicide as an outcome for mental disorders. A meta-analysis","volume":"170","author":"Harris","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0445","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.npp.1300450","article-title":"Effects of nicotine on cognitive deficits in schizophrenia","volume":"29","author":"Harris","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0450","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0893-133X(00)00237-2","article-title":"Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats","volume":"25","author":"Harrison","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0455","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00228-006-0209-9","article-title":"The effect of variable cigarette consumption on the interaction with clozapine and olanzapine","volume":"62","author":"Haslemo","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0460","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clpt.2005.08.007","article-title":"Safety and immunogenicity of a nicotine conjugate vaccine in current smokers","volume":"78","author":"Hatsukami","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0465","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0306-4603(98)00125-7","article-title":"Depression and smoking cessation: the role of motivation and self-efficacy","volume":"25","author":"Haukkala","year":"2000","journal-title":"Addict. Behav."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2011.06.007_bib0470","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2007-1014317","article-title":"Anhedonia in schizophrenic, depressed, or alcohol-dependent patients-neurobiological correlates","volume":"27","author":"Heinz","year":"1994","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0475","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)23319-5","article-title":"Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine","volume":"234","author":"Henningfield","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0485","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0006-8993(97)01135-9","article-title":"Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome","volume":"779","author":"Hildebrand","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0490","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/070674370905400604","article-title":"Treatment of tobacco dependence in mental health and addictive disorders","volume":"54","author":"Hitsman","year":"2009","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0495","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1568007043482507","article-title":"Nicotinic acetylcholine receptors as drug targets","volume":"3","author":"Hogg","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0500","article-title":"Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia","author":"Hong","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0505","first-page":"349","article-title":"Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia","volume":"1","author":"Horst","year":"2005","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0510","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1469-8986.1996.tb02370.x","article-title":"Effects of cigarette smoking on EEG spectral-band power, dimensional complexity, and nonlinearity during reaction-time task performance","volume":"33","author":"Houlihan","year":"1996","journal-title":"Psychophysiology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0515","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02246577","article-title":"Faster P300 latency after smoking in visual but not auditory oddball tasks","volume":"123","author":"Houlihan","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0520","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-002-1152-9","article-title":"Effects of selegiline (l-deprenyl) during smoking and short-term abstinence","volume":"163","author":"Houtsmuller","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0525","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/14622200701188927","article-title":"Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0530","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14622200701188919","article-title":"Effects of abstinence from tobacco: valid symptoms and time course","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0535","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugalcdep.2008.06.003","article-title":"Smoking and suicide: a brief overview","volume":"98","author":"Hughes","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0540","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/14622200500185298","article-title":"Nortriptyline for smoking cessation: a review","volume":"7","author":"Hughes","year":"2005","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0545","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","author":"Hughes","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0550","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.biopsych.2003.12.023","article-title":"Nicotine effects on brain function and functional connectivity in schizophrenia","volume":"55","author":"Jacobsen","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0555","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic\u2013adrenergic hypothesis of mania and depression","volume":"2","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0560","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S1461145704004742","article-title":"The combination of nicotine with the D2 antagonist raclopride or the weak D4 antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex","volume":"8","author":"Jardemark","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0565","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11920-999-0007-z","article-title":"Treatment of negative and cognitive symptoms","volume":"1","author":"Javitt","year":"1999","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0570","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrc2703","article-title":"Avoidable global cancer deaths and total deaths from smoking","volume":"9","author":"Jha","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0575","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0022-3565(24)37941-8","article-title":"Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers","volume":"288","author":"Jones","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 3","key":"10.1016\/j.neubiorev.2011.06.007_bib0580","first-page":"S176","article-title":"Anhedonia, self-experience in schizophrenia, and implications for treatment","volume":"36","author":"Juckel","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0585","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/10550490590924728","article-title":"Co-morbidity of smoking in patients with psychiatric and substance use disorders","volume":"14","author":"Kalman","year":"2005","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0590","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1176\/ajp.156.11.1751","article-title":"Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland","volume":"156","author":"Kelly","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0595","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archpsyc.1993.01820130038007","article-title":"Smoking and major depression. A causal analysis","volume":"50","author":"Kendler","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0600","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/mp.2008.78","article-title":"The association between smoking and subsequent suicide-related outcomes in the National Comorbidity Survey panel sample","volume":"14","author":"Kessler","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0605","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1037\/0022-006X.64.4.791","article-title":"Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement","volume":"64","author":"Kinnunen","year":"1996","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0610","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/070674370805301107","article-title":"Excess cancer mortality in psychiatric patients","volume":"53","author":"Kisely","year":"2008","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0615","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","article-title":"Smoking and mental illness: a population-based prevalence study","volume":"284","author":"Lasser","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0620","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrn1298","article-title":"The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour","volume":"5","author":"Laviolette","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0625","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1080\/j.1440-1614.2005.01697.x","article-title":"Smoking bans in psychiatric inpatient settings? A review of the research","volume":"39","author":"Lawn","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0630","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0896-6273(02)01004-8","article-title":"Cognitive mechanisms of nicotine on visual attention","volume":"36","author":"Lawrence","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0635","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/13543784.16.1.45","article-title":"Dopamine D3 receptor ligands for the treatment of tobacco dependence","volume":"16","author":"Le Foll","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0640","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0091-3057(01)00677-3","article-title":"Smoking and mental illness","volume":"70","author":"Leonard","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0645","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1208\/aapsj080108","article-title":"Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies","volume":"8","author":"LeSage","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0650","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/1064-1297.9.1.83","article-title":"Effects of chronic nicotine and methylphenidate in adults with attention deficit\/hyperactivity disorder","volume":"9","author":"Levin","year":"2001","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0655","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02246281","article-title":"Nicotine effects on adults with attention-deficit\/hyperactivity disorder","volume":"123","author":"Levin","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0660","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00213-005-0164-7","article-title":"Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization","volume":"184","author":"Levin","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0665","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000063629","article-title":"Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats","volume":"69","author":"Lindblom","year":"2002","journal-title":"Respiration"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0670","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00210-005-0019-0","article-title":"Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs","volume":"372","author":"Lindblom","year":"2005","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0675","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1139\/jpn.0933","article-title":"Treatment of comorbid tobacco use in people with serious mental illness","volume":"34","author":"Lising-Enriquez","year":"2009","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0680","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1176\/ps.50.10.1346","article-title":"A review of the effects of nicotine on schizophrenia and antipsychotic medications","volume":"50","author":"Lyon","year":"1999","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0685","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1360-0443.1997.tb02957.x","article-title":"Nicotine withdrawal in women","volume":"92","author":"Madden","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0690","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00213-006-0612-z","article-title":"Acute psychomotor, subjective and physiological responses to smoking in depressed outpatient smokers and matched controls","volume":"190","author":"Malpass","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0695","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/neu.10148","article-title":"Cellular and synaptic mechanisms of nicotine addiction","volume":"53","author":"Mansvelder","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0700","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00213-005-0070-z","article-title":"Nicotinic modulation of neuronal networks: from receptors to cognition","volume":"184","author":"Mansvelder","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0705","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0924-977X(95)00056-U","article-title":"Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens","volume":"6","author":"Marcus","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl. 16","key":"10.1016\/j.neubiorev.2011.06.007_bib0710","first-page":"3","article-title":"Overview of partial compliance","volume":"64","author":"Marder","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0715","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1046\/j.1460-9568.2003.02564.x","article-title":"Effects of nicotine in the dopaminergic system of mice lacking the \u03b14 subunit of neuronal nicotinic acetylcholine receptors","volume":"17","author":"Marubio","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0720","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature03694","article-title":"Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors","volume":"436","author":"Maskos","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0725","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1360-0443.2002.00064.x","article-title":"Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?","volume":"97","author":"McChargue","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0730","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2105\/AJPH.2009.188136","article-title":"Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey","volume":"100","author":"McClave","year":"2010","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0735","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jsat.2010.03.007","article-title":"Smoking outcome by psychiatric history after behavioral and varenicline treatment","volume":"38","author":"McClure","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0740","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1192\/bjp.181.4.321","article-title":"Use of drugs, alcohol and tobacco by people with schizophrenia: case\u2013control study","volume":"181","author":"McCreadie","year":"2002","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0745","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0006-3223(94)00365-A","article-title":"Clozapine decreases smoking in patients with chronic schizophrenia","volume":"37","author":"McEvoy","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0750","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02246063","article-title":"Haloperidol increases smoking in patients with schizophrenia","volume":"119","author":"McEvoy","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0755","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1001\/jama.2010.1769","article-title":"Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial","volume":"304","author":"McFall","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0760","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/mi.6.6.4","article-title":"Nicotinic and opioid receptor interactions in nicotine addiction","volume":"6","author":"McGehee","year":"2006","journal-title":"Mol. Interv."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2011.06.007_bib0765","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1055\/s-2007-992132","article-title":"Dopamine, prefrontal cortex and working memory functioning in schizophrenia","volume":"40","author":"Meisenzahl","year":"2007","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2011.06.007_bib0770","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1055\/s-2008-1081463","article-title":"The molecular and cellular neurobiology of nicotine abuse in schizophrenia","volume":"41","author":"Mobascher","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0775","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/10550490500247123","article-title":"Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice","volume":"14","author":"Montoya","year":"2005","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0780","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/070674370905400603","article-title":"Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders","volume":"54","author":"Morisano","year":"2009","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0785","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.npp.1301425","article-title":"Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray","volume":"33","author":"Myers","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0790","unstructured":"Nabi Biopharmaceutical\u00ae. Clinical Trials: NicVAX\u00ae (Nicotine Conjugate Vaccine). United States. Available at: http:\/\/www.nabi.com\/pipeline\/clinicaltrials.php#3 (accessed October 1, 2010)."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0800","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/syn.890160105","article-title":"Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area","volume":"16","author":"Nisell","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0805","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0773.1995.tb00123.x","article-title":"Nicotine dependence, midbrain dopamine systems and psychiatric disorders","volume":"76","author":"Nisell","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0810","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00001756-199903170-00007","article-title":"Nicotine withdrawal in the rat: role of \u03b17 nicotinic receptors in the ventral tegmental area","volume":"10","author":"Nomikos","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(96)00302-2","article-title":"Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers","volume":"42","author":"Olincy","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0820","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/00048670701392809","article-title":"Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective","volume":"41","author":"Olivier","year":"2007","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0825","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1176\/appi.ajp.161.8.1433","article-title":"Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder","volume":"161","author":"Oquendo","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0830","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7748\/ns.23.21.41.s50","article-title":"Poor physical health and mortality in patients with schizophrenia","volume":"23","author":"Pack","year":"2009","journal-title":"Nurs. Stand."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0835","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biopsych.2008.08.028","article-title":"Varenicline improves mood and cognition during smoking abstinence","volume":"65","author":"Patterson","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0840","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1360-0443.2008.02395.x","article-title":"Smoking, nicotine dependence and mental health among young adults: a 13-year population-based longitudinal study","volume":"104","author":"Pedersen","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0845","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0091-3057(99)00206-3","article-title":"A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats","volume":"65","author":"Pentel","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0850","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2105\/AJPH.80.12.1500","article-title":"Depressive symptoms and cigarette smoking among Latinos in San Francisco","volume":"80","author":"P\u00e9rez-Stable","year":"1990","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0855","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1096\/fj.03-0104fje","article-title":"The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes","volume":"17","author":"Perl","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0860","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000091725","article-title":"Low levels of alpha7-nicotinic acetylcholine receptor mRNA on peripheral blood lymphocytes in schizophrenia and its association with illness severity","volume":"53","author":"Perl","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0865","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4088\/JCP.08m04441","article-title":"Varenicline augmentation in depressed smokers: an 8-week, open-label study","volume":"70","author":"Philip","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0870","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","article-title":"It is not \u201ceither\/or\u201d: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood","volume":"84","author":"Picciotto","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0875","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/34413","article-title":"Acetylcholine receptors containing the \u03b22 subunit are involved in the reinforcing properties of nicotine","volume":"391","author":"Picciotto","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0880","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/37120","article-title":"Nicotine activates and desensitizes midbrain dopamine neurons","volume":"390","author":"Pidoplichko","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0885","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/14622200050147547","article-title":"Who gets what symptom? Effects of psychiatric cofactors and nicotine dependence on patterns of smoking withdrawal symptomatology","volume":"2","author":"Pomerleau","year":"2000","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0890","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0899-3289(95)90030-6","article-title":"Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder","volume":"7","author":"Pomerleau","year":"1995","journal-title":"J. Subst. Abuse"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0895","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/382255a0","article-title":"Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs","volume":"382","author":"Pontieri","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0900","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.drugalcdep.2004.04.017","article-title":"Depressed smokers and stage of change: implications for treatment interventions","volume":"76","author":"Prochaska","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0905","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1192\/bjp.bp.110.081372","article-title":"The smoking culture in psychiatry: time for change","volume":"198","author":"Ratschen","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0910","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0006-3223(00)01094-5","article-title":"Cognitive effects of nicotine","volume":"49","author":"Rezvani","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0915","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/1064-1297.16.3.215","article-title":"Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers","volume":"16","author":"Rohsenow","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0920","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","article-title":"Pharmacological profile of the \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid","volume":"52","author":"Rollema","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0925","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2009.01.002","article-title":"Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect","volume":"605","author":"Rollema","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0930","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(97)81951-6","article-title":"Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"338","author":"Rollema","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0935","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0376-8716(99)00025-3","article-title":"Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction","volume":"56","author":"Rose","year":"1999","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0940","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bcp.2009.06.098","article-title":"Insight in nAChR subtype selectivity from AChBP crystal structures","volume":"78","author":"Rucktooa","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0945","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/026988110401800403","article-title":"Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders","volume":"18","author":"Sacco","year":"2004","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0950","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/syn.10000","article-title":"Topiramate selectively attenuates nicotine-induced increases in monoamine release","volume":"42","author":"Schiffer","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0955","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145702003188","article-title":"Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes","volume":"6","author":"Schilstr\u00f6m","year":"2003","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0960","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.publhealth.012809.103701","article-title":"Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems","volume":"31","author":"Schroeder","year":"2010","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0965","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.addbeh.2010.03.020","article-title":"Individualized smoking cessation treatment in an outpatient setting: predictors of outcome in a sample with psychiatric and addictions co-morbidity","volume":"35","author":"Selby","year":"2010","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0970","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/BF02247416","article-title":"Psychomotor performance in smokers following single and repeated doses of nicotine gum","volume":"108","author":"Sherwood","year":"1992","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0975","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/14622200802027198","article-title":"Changes in psychiatric patients\u2019 thoughts about quitting smoking during a smoke-free hospitalization","volume":"10","author":"Shmueli","year":"2008","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0980","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1023\/B:NERE.0000035814.45494.15","article-title":"Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function","volume":"29","author":"Singer","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0985","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1360-0443.2009.02545.x","article-title":"Assessing motivation to quit smoking in people with mental illness: a review","volume":"104","author":"Siru","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0990","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.schres.2009.02.001","article-title":"Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder","volume":"110","author":"Smith","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0995","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0893-133X(02)00324-X","article-title":"Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia","volume":"27","author":"Smith","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1000","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s002130050129","article-title":"Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers","volume":"128","author":"Soria","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1176\/appi.ajp.160.2.316","article-title":"Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers","volume":"160","author":"Spring","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1010","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1523\/JNEUROSCI.0546-06.2006","article-title":"Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers","volume":"26","author":"Staley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1360-0443.2007.02083.x","article-title":"Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness","volume":"103","author":"Stapleton","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1020","first-page":"CD000146","article-title":"Nicotine replacement therapy for smoking cessation","author":"Stead","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1025","first-page":"206","article-title":"Financial implications of cigarette smoking among individuals with schizophrenia","volume":"13","author":"Steinberg","year":"2004","journal-title":"Tob. Control"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(99)00886-9","article-title":"Nicotine in an animal model of attention","volume":"393","author":"Stolerman","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1566-2772(03)00017-3","article-title":"Preclinical effects of conventional and atypical antipsychotic drugs: defining the mechanisms of action","volume":"3","author":"Svensson","year":"2003","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1040","first-page":"26","article-title":"A study of reasons of non-compliance to psychiatric treatment","volume":"17","author":"Taj","year":"2005","journal-title":"J. Ayub. Med. Coll. Abbottabad"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1176\/ajp.147.2.207","article-title":"Emergence of intense suicidal preoccupation during fluoxetine treatment","volume":"147","author":"Teicher","year":"1990","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1050","first-page":"291","article-title":"Withdrawal from nicotine dependence using mecamylamine: comparison of three-week and six-week dosage schedules","volume":"55","author":"Tennant","year":"1984","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1055","first-page":"239","article-title":"Clinical evaluation of mecamylamine for withdrawal from nicotine dependence","volume":"49","author":"Tennant","year":"1984","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1060","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/sj.npp.1300633","article-title":"Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex","volume":"30","author":"Thiel","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.psc.2004.06.004","article-title":"The basal ganglia: anatomy, physiology, and pharmacology","volume":"27","author":"Tisch","year":"2004","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/11319180-000000000-00000","article-title":"Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis","volume":"33","author":"Tonstad","year":"2010","journal-title":"Drug Saf."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1192\/bjp.bp.109.066019","article-title":"Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis","volume":"196","author":"Tsoi","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1080","first-page":"CD007253","article-title":"Interventions for smoking cessation and reduction in individuals with schizophrenia","volume":"6","author":"Tsoi","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1085","unstructured":"U.S. Department of Health and Human Services. The health consequences of smoking: nicotine addiction: a report of the Surgeon General. 1988 U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health. Available at: http:\/\/profiles.nlm.nih.gov\/NN\/B\/B\/Z\/D\/_\/nnbbzd.pdf (accessed October 1, 2010)."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1090","unstructured":"U.S. Department of Health and Human Services. The health benefits of smoking cessation: a report of the Surgeon General. DHHS Publication No. (CDC) 90-8416. U.S. Department of Health and Human Services. Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 1990. Available at: http:\/\/profiles.nlm.nih.gov\/NN\/B\/B\/C\/V\/_\/nnbbcv.pdf (accessed October 1, 2010)."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1095","unstructured":"U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. 2010 U.S. Department of Health and Human Services, Public Health Service, Office of Surgeon General. Available at: http:\/\/www.surgeongeneral.gov\/library\/tobaccosmoke\/report\/executivesummary.pdf (accessed February 17, 2011)."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1100","unstructured":"U.S. Food and Drug Administration. Early communication about an ongoing safety review: varenicline (marketed as Chantix). U.S. Department of Health and Human Services. November 20, 2007. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm070765.htm (accessed October 1, 2010)."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1105","unstructured":"U.S. Food and Drug Administration. Public health advisory: important information on Chantix (varenicline). U.S. Department of Health and Human Services. February 1, 2008. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/PublicHealthAdvisories\/ucm051136.htm (accessed October 1, 2010)."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1110","unstructured":"U.S. Food and Drug Administration. Information for healthcare professionals: varenicline (marketed as Chantix) and bupropion (marketed as Zyban, Wellbutrin, and generics). U.S. Department of Health and Human Services. July 1, 2009. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm169986.htm (accessed October 1, 2010)."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib0305","unstructured":"FDA. The smoking cessation aids varenicline (marketed as Chantix) and bupropion (marketed as Zyban and generics): suicidal ideation and behavior. FDA Drug Safety Newsletter vol. 2(1). 2009. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/DrugSafetyNewsletter\/ucm110235.htm (accessed October 1, 2010)."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14622200050011277","article-title":"Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal","volume":"2","author":"Watkins","year":"2000","journal-title":"Nicotine Tob. Res."},{"issue":"Suppl. 4","key":"10.1016\/j.neubiorev.2011.06.007_bib1120","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/00004850-199709004-00006","article-title":"Cognitive function in schizophrenia","volume":"12","author":"Weinberger","year":"1997","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000117969","article-title":"Effects of smoking on rapid information processing performance","volume":"9","author":"Wesnes","year":"1983","journal-title":"Neuropsychobiology"},{"issue":"5","key":"10.1016\/j.neubiorev.2011.06.007_bib1130","article-title":"Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion","volume":"12","author":"Wightman","year":"2010","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/09595230500459560","article-title":"Smoking cessation and depression: current knowledge and future directions","volume":"25","author":"Wilhelm","year":"2006","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1140","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.addbeh.2004.03.009","article-title":"Addressing tobacco among individuals with a mental illness or an addiction","volume":"29","author":"Williams","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.schres.2005.04.016","article-title":"Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect","volume":"79","author":"Williams","year":"2005","journal-title":"Schizophr. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2011.06.007_bib1150","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1055\/s-2006-931498","article-title":"Cortical microcircuits in schizophrenia\u2014the dopamine hypothesis revisited","volume":"39","author":"Winterer","year":"2006","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2011.06.007_bib1155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2007-992810","article-title":"Prefrontal dopamine signaling in schizophrenia-the corticocentric model","volume":"40","author":"Winterer","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1160","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/appi.ajp.161.3.490","article-title":"Prefrontal broadband noise, working memory, and genetic risk for schizophrenia","volume":"161","author":"Winterer","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1165","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.biopsych.2006.03.023","article-title":"Prefrontal electrophysiologic \u201cnoise\u201d and catechol-O-methyltransferase genotype in schizophrenia","volume":"60","author":"Winterer","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2011.06.007_bib1170","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ajmg.b.31126","article-title":"Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance","volume":"153B","author":"Winterer","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1175","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1176\/ajp.2006.163.11.1960","article-title":"Instability of prefrontal signal processing in schizophrenia","volume":"163","author":"Winterer","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2004.12.002","article-title":"Nicotine: from molecular mechanisms to behaviour","volume":"5","author":"Wonnacott","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1185","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.pnpbp.2008.08.022","article-title":"Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors","volume":"32","author":"Wu","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2007.10.011","article-title":"Smoking upregulates alpha4beta2* nicotinic acetylcholine receptors in the human brain","volume":"430","author":"Wullner","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/1471-2458-10-372","article-title":"Total smoking bans in psychiatric inpatient services: a survey of perceived benefits, barriers and support among staff","volume":"10","author":"Wye","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1200","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1037\/0021-843X.107.4.691","article-title":"P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects","volume":"107","author":"Yee","year":"1998","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10802-007-9163-y","article-title":"A dimensional model of psychopathology among homeless adolescents: suicidality, internalizing, and externalizing disorders","volume":"36","author":"Yoder","year":"2008","journal-title":"J. Abnorm. Child Psychol."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1210","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1080\/14622200802443569","article-title":"Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report","volume":"10","author":"Ziedonis","year":"2008","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neubiorev.2011.06.007_bib1215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00000441-200310000-00014","article-title":"Serious mental illness and tobacco addiction: a model program to address this common but neglected issue","volume":"326","author":"Ziedonis","year":"2003","journal-title":"Am. J. Med. Sci."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763411001175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763411001175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:11:31Z","timestamp":1758964291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763411001175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":242,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0149763411001175"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2011.06.007","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Smoking, quitting, and psychiatric disease: A review","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2011.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}